News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
724,636 Results
Type
Article (57716)
Company Profile (200)
Press Release (666718)
Multimedia
Podcasts (115)
Webinars (19)
Section
Business (204285)
Career Advice (2964)
Deals (35012)
Drug Delivery (121)
Drug Development (81896)
Employer Resources (190)
FDA (16428)
Job Trends (15288)
News (345977)
Policy (33313)
Tag
Academia (2894)
Academic (2)
Accelerated approval (9)
Adcomms (30)
Allergies (105)
Alliances (50955)
ALS (118)
Alzheimer's disease (1539)
Antibody-drug conjugate (ADC) (172)
Approvals (16394)
Artificial intelligence (363)
Autoimmune disease (33)
Automation (18)
Bankruptcy (350)
Best Places to Work (12074)
BIOSECURE Act (21)
Biosimilars (129)
Biotechnology (135)
Bladder cancer (98)
Brain cancer (38)
Breast cancer (381)
Cancer (3008)
Cardiovascular disease (238)
Career advice (2508)
Career pathing (34)
CAR-T (205)
CDC (38)
Cell therapy (553)
Cervical cancer (23)
Clinical research (66999)
Collaboration (1087)
Company closure (3)
Compensation (673)
Complete response letters (26)
COVID-19 (2772)
CRISPR (67)
C-suite (352)
Cystic fibrosis (116)
Data (3061)
Decentralized trials (2)
Denatured (38)
Depression (75)
Diabetes (364)
Diagnostics (6739)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (156)
Drug pricing (139)
Drug shortages (34)
Duchenne muscular dystrophy (128)
Earnings (83480)
Editorial (48)
Employer branding (25)
Employer resources (165)
Events (118460)
Executive appointments (905)
FDA (18108)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (987)
Gene editing (145)
Generative AI (35)
Gene therapy (424)
GLP-1 (902)
Government (4870)
Grass and pollen (6)
Guidances (181)
Healthcare (20046)
HIV (43)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (179)
Immuno-oncology (10)
Indications (39)
Infectious disease (2965)
Inflammatory bowel disease (163)
Inflation Reduction Act (13)
Influenza (70)
Intellectual property (121)
Interviews (592)
IPO (16538)
IRA (53)
Job creations (3642)
Job search strategy (2066)
Kidney cancer (15)
Labor market (52)
Layoffs (536)
Leadership (26)
Legal (7972)
Liver cancer (83)
Longevity (11)
Lung cancer (422)
Lymphoma (214)
Machine learning (11)
Management (63)
Manufacturing (415)
MASH (99)
Medical device (13855)
Medtech (13859)
Mergers & acquisitions (19226)
Metabolic disorders (925)
Multiple sclerosis (104)
NASH (23)
Neurodegenerative disease (136)
Neuropsychiatric disorders (39)
Neuroscience (2280)
NextGen: Class of 2025 (7001)
Non-profit (4872)
Now hiring (48)
Obesity (477)
Opinion (278)
Ovarian cancer (103)
Pain (116)
Pancreatic cancer (123)
Parkinson's disease (198)
Partnered (21)
Patents (312)
Patient recruitment (167)
Peanut (54)
People (59816)
Pharmaceutical (53)
Pharmacy benefit managers (20)
Phase I (20683)
Phase II (29307)
Phase III (22371)
Pipeline (1675)
Policy (231)
Postmarket research (2792)
Preclinical (9049)
Press Release (71)
Prostate cancer (149)
Psychedelics (45)
Radiopharmaceuticals (270)
Rare diseases (514)
Real estate (5852)
Recruiting (75)
Regulatory (23108)
Reports (57)
Research institute (2560)
Resumes & cover letters (445)
Rett syndrome (10)
RNA editing (9)
RSV (57)
Schizophrenia (97)
Series A (171)
Series B (116)
Service/supplier (11)
Sickle cell disease (66)
Special edition (19)
Spinal muscular atrophy (160)
Sponsored (35)
Startups (3784)
State (2)
Stomach cancer (16)
Supply chain (83)
Tariffs (59)
The Weekly (75)
Vaccines (844)
Venture capital (55)
Weight loss (311)
Women's health (47)
Worklife (20)
Date
Today (73)
Last 7 days (396)
Last 30 days (2000)
Last 365 days (32807)
2025 (17720)
2024 (36716)
2023 (41603)
2022 (52825)
2021 (57411)
2020 (55825)
2019 (48914)
2018 (37042)
2017 (34178)
2016 (33755)
2015 (39284)
2014 (31960)
2013 (27404)
2012 (28847)
2011 (29354)
2010 (27629)
Location
Africa (983)
Alabama (67)
Alaska (7)
Arizona (226)
Arkansas (14)
Asia (42718)
Australia (7917)
California (7573)
Canada (2382)
China (704)
Colorado (333)
Connecticut (339)
Delaware (194)
Europe (98043)
Florida (1134)
Georgia (259)
Hawaii (2)
Idaho (55)
Illinois (682)
India (30)
Indiana (376)
Iowa (16)
Japan (236)
Kansas (108)
Kentucky (30)
Louisiana (16)
Maine (73)
Maryland (1075)
Massachusetts (5753)
Michigan (270)
Minnesota (471)
Mississippi (3)
Missouri (100)
Montana (26)
Nebraska (25)
Nevada (79)
New Hampshire (73)
New Jersey (2152)
New Mexico (29)
New York (2142)
North Carolina (1155)
North Dakota (9)
Northern California (3330)
Ohio (240)
Oklahoma (16)
Oregon (34)
Pennsylvania (1634)
Puerto Rico (18)
Rhode Island (36)
South America (1338)
South Carolina (34)
South Dakota (1)
Southern California (2844)
Tennessee (124)
Texas (1147)
United States (28441)
Utah (227)
Virginia (196)
Washington D.C. (76)
Washington State (654)
West Virginia (4)
Wisconsin (80)
724,636 Results for "tekla life sciences investors formerly known as h and q life sciences investors".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
Life Sciences Employment Growth in California Slows—and Could Keep Slowing
California’s life sciences jobs led the nation last year, according to a new California Life Sciences (CLS) report. However, employment growth slowed and could continue slowing. CLS President and CEO Mike Guerra discusses the critical factors influencing California’s success.
June 20, 2025
·
4 min read
·
Angela Gabriel
Business
New Jersey’s Life Sciences Scene Continues Expanding Beyond Big Pharma
Known as the home of big-name companies including Johnson & Johnson, New Jersey has become a destination for more and more small and midsize life sciences businesses. Choose New Jersey, Grace Therapeutics and Onyx Equities executives discuss the state’s life sciences scene.
April 10, 2025
·
6 min read
·
Angela Gabriel
Press Releases
atai Life Sciences to Participate in Upcoming Investor Conferences
May 29, 2025
·
1 min read
IN PARTNERSHIP WITH PATSNAP
Webinar: Beyond Theory: Real-World AI Wins in Life Science R&D, Faster & Smarter
Are long R&D cycles, overwhelming literature reviews, or patent bottlenecks slowing your path to innovation? In the fast-evolving life science landscape, AI is no longer a luxury, it’s a necessity.
June 25, 2025
·
1 min read
·
BioSpace Insights
Press Releases
Bio-Path Holdings to Present at Life Sciences Virtual Investor Forum
June 9, 2025
·
3 min read
Venture capitalists
Blackstone Launches New $5B+ Fund for Life Sciences
Blackstone joins other big investors such as ARCH Venture Partners and Bain Capital Life Sciences in pumping billions of dollars into the industry.
January 31, 2025
·
2 min read
·
Tristan Manalac
Job Trends
Massachusetts’ Life Sciences Job Growth Flattens After 10+ Years of Increases: Report
Massachusetts’ life sciences jobs grew by just 0.03% in 2024, according to a new MassBioEd report. Still, the report found encouraging signs for the industry, noting it’s expected to grow by 11.6% by 2029, adding an estimated 16,633 net new positions.
June 4, 2025
·
3 min read
·
Angela Gabriel
Press Releases
IMUNON to Present at the Zacks SCR Life Sciences Virtual Investor Forum on June 12th
June 5, 2025
·
3 min read
Job Trends
Report: 2025 U.S. Life Sciences Salary Report
March 25, 2025
·
1 min read
·
BioSpace Insights
Business
Houston’s Life Sciences Scene Continues Boosting Its Reputation
While Houston isn’t yet on the same level as major life sciences hubs, it has plenty to offer and room to grow, according to CNS Pharmaceuticals, RadioMedix and Greater Houston Partnership executives.
March 13, 2025
·
6 min read
·
Angela Gabriel
1 of 72,464
Next
